EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Endocrine-driven inflammatory–epigenetic adaptation as a proposed axis of radioresistance in endocrine-exposed prostate cancer: a translational hypothesis

Miloš Grujić, Marija Živković Radojević, Tinatin Alaverdashvili, Imdat Eroglu, Katarina Krasić, Katarina Janković, Neda Milosavljević

Frontiers in Endocrinology · 23.06.2026 · 17

DOI: 10.3389/fendo.2026.1851378 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Endocrinology, online erschienen am 23.06.2026. Verfasst von Miloš Grujić und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Kragujevac, Serbia, Faculty of Medical Sciences, Kragujevac, Serbia. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Epigenesis, Genetic, Radiation Tolerance, Inflammation. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy response in prostate cancer is commonly interpreted through partly separate frameworks centered on androgen receptor (AR) signaling, DNA damage response (DDR), inflammatory adaptation, and lineage plasticity. Here, we propose a translational hypothesis particularly relevant to endocrine-exposed disease in settings of biologically meaningful endocrine exposure before or during radiotherapy, especially high-risk localized, locally advanced, and selected salvage settings: the radiosensitizing effect of AR suppression may be temporally dynamic rather than fixed. In a subset of tumors, sustained endocrine pressure may initially impair AR-dependent DDR signaling but subsequently promote adaptive inflammatory signaling and epigenetic remodeling that attenuate this benefit and favor relative radioresistance. We propose a sequence-level model in which endocrine therapy acts as the initiating biologic stressor, inflammatory signaling functions as the adaptive amplifier, and epigenetic remodeling stabilizes a more durable treatment-tolerant state that becomes functionally revealed in the radiotherapy setting. While several bilateral links within this framework are supported by existing literature, the full temporally ordered cascade should be regarded as inferential and hypothesis-generating. The novelty of this framework lies not in proposing a new pathway, but in reframing endocrine-associated radiosensitization as a dynamic biologic state that may diverge over time across apparently similar treatment paradigms. This model yields clear translational predictions: endocrine-exposed tumors should differ in their propensity to develop adaptive inflammatory activation, inflammatory-high states should show attenuated radiosensitization and more repair-supportive features, and serial biomarker profiling across endocrine exposure and radiotherapy should outperform baseline-only assessment for identifying emerging resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsEpigenesis, GeneticRadiation ToleranceInflammationHumansMaleReceptors, AndrogenAnimalsAdaptation, Physiological

Stichwörter der Autor:innen

IL-6/STAT3androgen deprivation therapyandrogen receptorepigenetic remodelinglineage plasticityprostate cancerradioresistanceradiotherapy

Substanzen

Receptors, Androgen

Autor:innen und Institutionen

  • University of Kragujevac, Serbia, Faculty of Medical Sciences, Kragujevac, Serbia.
  • Clinic of Radiation Oncology, University Clinical Center Kragujevac, Kragujevac, Serbia.
  • University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Clinical Oncology, Kragujevac, Serbia.
  • Radiation Oncology Department, Todua Clinic, Tbilisi, Georgia.
  • Gazi University School of Medicine, Department of Medical Oncology, Ankara, Türkiye.

Zitieren

APA

Grujić, M., Živković Radojević, M., Alaverdashvili, T., Eroglu, I., Krasić, K., Janković, K., & Milosavljević, N. (2026). Endocrine-driven inflammatory–epigenetic adaptation as a proposed axis of radioresistance in endocrine-exposed prostate cancer: a translational hypothesis. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.1851378

Vancouver

Grujić M, Živković Radojević M, Alaverdashvili T, Eroglu I, Krasić K, Janković K, et al. Endocrine-driven inflammatory–epigenetic adaptation as a proposed axis of radioresistance in endocrine-exposed prostate cancer: a translational hypothesis. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.1851378

BibTeX
@article{Gruji2026,
  author = {Grujić, Miloš and Živković Radojević, Marija and Alaverdashvili, Tinatin and Eroglu, Imdat and Krasić, Katarina and Janković, Katarina and Milosavljević, Neda},
  title = {Endocrine-driven inflammatory–epigenetic adaptation as a proposed axis of radioresistance in endocrine-exposed prostate cancer: a translational hypothesis},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fendo.2026.1851378}
}
Kostenlos starten →